Robert C. Colloton serves as Executive at MICRUS ENDOVASCULAR CORP, where they oversee executive responsibilities. Since joining the company, Robert C. Colloton has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 27, 2010 involved selling 25 shares valued at $0.
Robert C. Colloton currently holds 25 shares of MICRUS ENDOVASCULAR CORP (MEND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert C. Colloton has been a net neutral trader of MEND stock. They have purchased $0 and sold $0 worth of shares.
Robert C. Colloton's most recent insider trade was on Sep 27, 2010, when they sold 25 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |